Join to View Full Profile
701 S Parker StSte 1000Orange, CA 92868
Phone+1 714-221-1200
Fax+1 714-221-1299
Dr. Gomez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCSF Benioff Children’s Hospital OaklandFellowship, Pediatric Hematology/Oncology, 2011 - 2014
University of Arizona College of Medicine-PhoenixResidency, Internal Medicine/Pediatrics, 2007 - 2011
David Geffen School of Medicine at UCLAClass of 2007
Certifications & Licensure
CA State Medical License 1990 - 2027
AZ State Medical License 2014 - 2023
NV State Medical License Active through 2023
American Board of Internal Medicine Internal Medicine
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Completion of Phase 2b trial of etranacogene dezaparvovec gene therapy in patients with hemophilia B over 5 years.Annette von Drygalski M.D, Esteban Gomez, Adam Giermasz, Giancarlo Castaman, Nigel S Key
Blood Advances. 2025-04-06 - Invasive procedures and surgery following etranacogene dezaparvovec gene therapy in people with hemophilia B.Niamh O'Connell, Paul van der Valk, Sandra Le Quellec, Esteban Gomez, Paul E Monahan
Journal of Thrombosis and Haemostasis. 2025-01-01 - 20 citationsStable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapy.Annette von Drygalski, Esteban Gomez, Adam Giermasz, Giancarlo Castaman, Nigel S Key
Blood Advances. 2023-10-10
Abstracts/Posters
- Use of a Electronic Sickle Cell Dashboard to Improve Annual Transcranial Doppler Ultrasound (TCD) Completion RatesEsteban Gomez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- One Year Data from a Phase 2b Trial of AMT-061 (AAV5-Padua hFIX variant), an Enhanced Vector for Gene Transfer in Adults with Severe or Moderate-Severe Hemophilia BEsteban Gomez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Assessing Efficacy of Provider and Family Education, Electronic Health Record Documentation Tools, and Information Technology to Increase Use of Hydroxyurea in Childre...Esteban Gomez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
